The deal – details of which were not disclosed – will see Recipharm conduct formulation development work at its site in Solna, near Stockholm. The contract manufacturing firm said that it is in talks with Astimex regardsing “other manufacturing and development contractual projects.”
This was confirmed by Astimex general manager ASA Lintzen who said: “It is Recipharm’s recognised partnering approach, combined with its advanced and adaptable capabilities, including its offering at the Solna facility that attracted us in the first place.”
She added: “Moreover, we were looking for a CDMO that we could build a long term relationship with and consequently we are already exploring the scope for working with Recipharm on other projects.”